Live Breaking News & Updates on Peking Union University

Stay updated with breaking news from Peking union university. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer

For patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, pyrotinib plus capecitabine offers an overall survival benefit. ....

Binghe Xu , Union University , Fudan University Cancer Hospital , Chinese Academy Of Medical Sciences , Breast Cancer Seventh International Consensus Conference , Jiangsu Hengrui Pharmaceuticals , Healthday News , Chinese Academy , Medical Sciences , Peking Union University ,

Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer

THURSDAY, Nov. 16, 2023 (HealthDay News) For patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, pyrotinib plus capecitabine offers an overall survival benefit, according to a study presented at the Advanced Breast Cancer Seventh International Consensus Conference, held from Nov. 9 to 11 in Lisbon, Portugal. Binghe Xu, M.D., from ....

Binghe Xu , Fudan University Cancer Hospital , Breast Cancer Seventh International Consensus Conference , Union University , Chinese Academy Of Medical Sciences , Jiangsu Hengrui Pharmaceuticals , Healthday News , Chinese Academy , Medical Sciences , Peking Union University ,